Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several tumour-forming cell lines are known to secrete the precursor of a lysosomal cysteine proteinase, procathepsin L. The function in tumour growth and proliferation of this neutral-pH-labile proteinase or its precursor outside lysosomes is as yet unknown. Murine
myeloma
cells (P3X63Ag8.653) secrete procathepsin L and exhibit a high potential for malignant tumour growth and metastasis. Such cells were fused with spleen cells of mice immunized with
cathepsin L
. Clones of the resulting hybridoma cells continued to secrete procathepsin L, but also secreted the antibody to
cathepsin L
. Here we show that the hybridoma cells producing an antibody to
cathepsin L
have, to a great extent, lost the potential that they otherwise exhibit for inducing solid tumours after implantation into mice.
...
PMID:Hybridoma cells producing antibodies to cathepsin L have greatly reduced potential for tumour growth. 804 24
Human procathepsin L (25mg) was highly purified from the culture filtrate (4L) of mouse
myeloma
cells (Sp-HCL/HE14) transformed with human procathepsin L cDNA. The procathepsin L was almost completely converted to the mature form (18mg) under the acidic condition. Some properties of the mature
cathepsin L
were found to be different from those of the human liver-derived enzyme. In addition, we first produced crystals of mature human
cathepsin L
with E-64 using polyethylene glycol 6000 as the precipitant. The crystal was orthorhombic and belonged to the space group P2(1)2(1)2(1). The unit cell dimensions were: a = 49.8 A, b = 103.9 A, c = 47.8 A. The cell volume (2.47 x 10(5) A3) and calculated molecular mass (24.6 kDa) gave a volume/mass ratio of 2.5 A3/Da, which indicates that the asymmetric unit contains one molecule of enzyme.
...
PMID:Characterization and crystallization of recombinant human cathepsin L. 894 55
Human procathepsin L is highly expressed in mouse
myeloma
cells and processed into the mature enzyme under the acidic condition below pH 5.5. Different from the mature enzyme, it is stable at a neutral pH. To examine whether or not procathepsin L is autoprocessed intramolecularly, we constructed a mutant procathepsin L cDNA in which the codon for Cys138 proposed as the active site was mutated to encode Ser by PCR-mutagenesis. The mutant procathepsin L (C138S) was secreted into the culture medium from mouse
myeloma
cells expressing this mutant cDNA, but not processed into the mature form under the acidic condition. In addition, the mutant C138S was not processed by the incubation at 37 degrees C with wild-type procathepsin L or mature
cathepsin L
under the acidic condition. These findings showed that Cys138 is the active site of
cathepsin L
and that the autocatalytic processing occurs intramolecularly.
...
PMID:Processing properties of recombinant human procathepsin L. 902 32
Several tumour-forming cell lines are known to overproduce the lysosomal cysteine peptidase
cathepsin L
. We have used an antisense approach to investigate whether inhibition of
cathepsin L
overexpression in two malignant cell lines (
myeloma
SP cells and L cells) reduces their tumorigenic potential. Two different cDNA fragments of murine
cathepsin L
were inserted in the antisense direction into the pcDNA3 vector, and SP and L cells were stably transfected with these plasmid constructs. Several of the selected clones expressing the antisense transcript showed specific reduction of the mRNA level and the intracellular activity of
cathepsin L
, and a greatly diminished amount of secreted procathepsin L. When tested in Balb/c nu/nu mice, the cell lines with low
cathepsin L
activity exhibited a significantly decreased potential for tumour growth when compared with control cells expressing wild-type levels of
cathepsin L
activity. This observation suggests that
cathepsin L
is a critical factor in tumour growth.
...
PMID:Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. 1076 53
Zymography of concentrated conditioned medium (CM) from protein-free NS0
myeloma
cell cultures showed that this cell line produced and released/secreted several proteases. Two caseinolytic activities at 45-50 and 90 kDa were identified as aspartic acid proteases, and at least two cathepsins of the papain-like cysteine protease family with molecular masses of 30-35 kDa were found by gelatin zymography. One of these cathepsins was identified as
cathepsin L
by using an enzyme assay exploiting the substrate Z-Phe-Arg-AMC and the inhibitor Z-Phe-Tyr-t(Bu)-DMK. The aspartic acid and cysteine proteases were active only at acidic pH and are therefore not a potential risk for degrading the product or affecting cell growth during culture. Secreted proforms of cathepsins may, however, possess mitogenic functions, but addition of anti-procathepsin L antibodies to NS0 cultures did not influence proliferation. The recombinant antibody product was not degraded in cell-free CM incubated at pH 7, but when the pH was decreased to 3.5-4, the aspartic acid proteases degraded the product. Gelatin zymography also revealed the presence of several serine proteases in NS0 CM, one at 85 kDa and two at 50 kDa, with pH optima close to culture pH. Addition of the serine protease inhibitor aprotinin significantly increased the specific proliferation rate as compared to the control. In addition to these data, N-terminal amino acid sequencing identified two proteins in NS0 CM as the protease inhibitors secretory leukocyte protease inhibitor and cystatin C.
...
PMID:Protease activity in protein-free NS0 myeloma cell cultures. 1644 22